38 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
and President of privately-held, South Carolina-based Samothrace Medical Innovations, Inc., which he co-founded in March 2022. Until his retirement
DRS/A
EX-10.24
st48xpocmmojezc
23 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.24
2m58g
29 Oct 20
IPO registration
5:04pm
PRE 14A
k60ia5acb83syv
9 Apr 21
Preliminary proxy
4:16pm
DEF 14A
3hkusbnl9oed cjo1
19 Apr 21
Definitive proxy
4:46pm
DRS/A
EX-10.13
obkvd7v8m75gsd 8kh
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.14
ripkhvd2179562nk a5w
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.14
1nxj7avpyamvye
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.13
zrs04hzwdsm
29 Oct 20
IPO registration
5:04pm
424B4
elcspwliamifm 3mkw7g
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
j7h5u8
25 Mar 21
Draft registration statement
12:00am
S-8
EX-10.1
hgvesuaf3b1xgem
23 Nov 20
Registration of securities for employees
5:06pm
8-K
EX-2.1
qn8 exc1j
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
8-K
EX-3.2
qq0ypyuaie 2wxqw88dh
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am